Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Drug Alcohol Depend. 2008 Dec 5;101(1-2):34–41. doi: 10.1016/j.drugalcdep.2008.10.016

Figure 3.

Figure 3

3A. Cocaine-use proportion in the intention-to-treat sample. Beginning (week 1 of treatment) and ending (week 8 of treatment) sample sizes are shown in the legend. The SR group had significantly fewer BE-positive urine tests than the placebo (0 mg) or IR conditions. 3B. Cocaine-use proportion in those completing treatment. Samples sizes are shown in the legend. The SR group had significantly fewer BE-positive urine tests than the placebo (0 mg) or IR conditions.